HDAC9 and Huntington disease: Notably, in our experiments we detected no changes in levels of α-tubulin acetylation in HD animals, and furthermore, the extent of deacetylase inhibition in cortical extracts from R6/2 and wild-type mice treated with a HDAC class II selective inhibitor were identical.